Garza-Cruz MA, Berber-Mendoza LR, Ibarra-Sánchez RI, Barba-Padilla M, Ojeda-García EA, Barragán-Medina JA, Topete-Reyes JF

Language: Spanish
References: 14
Page: 38-47
PDF size: 582.20 Kb.

ABSTRACT

Objective: The objective of this study was to describe the prevalence of ambient factors, and antigenspecific subcutaneous test. And evaluate the impact of immunotherapy after 2 years of treatment. Material and methods: An observational, analytic, retrospective study. Which analyzed patients with asthma and/or allergic rhinitis diagnose, with subcutaneous antigen-specific and positive IgE blood test, we included patients from the pediatric and otorhinolaryngology consult from the municipal health service of Tlajomulco de Zuñiga, Jalisco on the period 2012-2014. We use the Pediatric Asthma Quality of Life Questionnaire (PAQLQ) to compare the pre and post therapy test. Outcome: The 90.09% of Tlajomulco de Zuñiga are conform by non-urban ground. Mites, oak and cedar conform 79.16% of positive antigen-specific subcutaneous test. We observed on the pre-test mean activity limitation score was significantly higher than that the post-test 1.8 (p ‹0.00), on symptoms score the mean difference was 1.9 (p ‹0.000), on emotional score the difference was 1.7 (p 0.000) and global score a difference of 1.8 (p‹0.00). Conclusions: There is a significant association between improvement in quality of life after two years of treatment with immunotherapy in patients from 5 to 17 years with asthma and/or rhinitis diagnosis, in Tlajomulco de Zuñiga.

REFERENCES

1. Pedersen SE, et al., Global strategy for the diagnosis and management of asthma in children 5 years and younger. Pediatr Pulmonol, 2011. 46(1): p. 1-17.

2. Martinez FD, et al., Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med, 1995. 332(3): p. 133-8.

3. Eder, W., M.J. Ege, and E. von Mutius, The asthma epidemic . N Engl J Med, 2006. 355(21): p. 2226-35.

4. Sataloff RT, et al., Practice parameter: laryngeal electro myography (an evidence-based review). Otolaryngol Head Neck Surg, 2004. 130(6): p. 770-9.

5. Sataloff R., et al., Practice parameter: laryngeal electro myography (an evidence-based review). J Voice, 2004. 18(2): p. 261-74.

6. Rao SP, et al., A role for guanylate cyclase C in acid-sti mulated duodenal mucosal bicarbonate secretion. Am J Physiol Gastrointest Liver Physiol, 2004. 286(1): p. G95-G101.

7. Lloyd CM, EM Hessel, Functions of T cells in asthma: more than just T(H)2 cells. Nat Rev Immunol, 2010. 10(12): p. 838- 48.

8. Bel EH, Mild asthma. N Engl J Med, 2013. 369(24): p. 2362.

9. Schembri S, Asthma in pregnancy. N Engl J Med, 2009. 361(5 ): p. 535; author reply 535-6.

10. Lennard CM, et al., Interleukin-1 beta, interleukin-5, in terleukin-6, interleukin-8, and tumor necrosis factor-alpha in chronic sinusitis: response to systemic corticosteroids. Am J Rhinol, 2000. 14(6): p. 367-73.

11. Roy N, et al. Protein kinase C regulates transcription of the human guanylate cyclase C gene. Eur J Biochem, 2001. 268(7): p. 2160-71.

12. Turner SW, et al., A methodology to establish a database to study gene environment interactions for childhood asthma. BMC Med Res Methodol, 2010. 10: p. 107.

13. Zapatero L, et al., Clinical evolution of patients with r espiratory allergic disease due to sensitisation to Alternaria alternata being treated with subcutaneous immunotherapy. Allergol Immunopathol (Madr), 2011. 39(2): p. 79-84.

14. Gozde-Kanmaz H, et al., Specifi c immunotherapy improves a sthma related quality of life in childhood. Allergol Immunopathol (Madr), 2011. 39(2): p. 68-72.